Recent Progress in Dendritic Cell-Based Cancer Immunotherapy

Recent Progress in Dendritic Cell-Based Cancer Immunotherapy

Cancer immunotherapy aims to treat cancer by enhancing cancer-specific host immune responses. Recently, cancer immunotherapy has been attracting much attention because of the successful clinical application of immune checkpoint inhibitors targeting the CTLA-4 and PD-1/PD-L1 pathways. However, althou...

Full description

Bibliographic Details
Main Authors:	Kazuhiko Matsuo, Osamu Yoshie, Kosuke Kitahata, Momo Kamei, Yuta Hara, Takashi Nakayama
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	Cancers
Subjects:	cancer vaccine adjuvant dendritic cells chemokine XCR1 XCL1
Online Access:	https://www.mdpi.com/2072-6694/13/10/2495

Similar Items

A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8+ T Cells
by: Kazuhiko Matsuo, et al.
Published: (2018-11-01)

Rat cytomegalovirus efficiently replicates in dendritic cells and induces changes in their transcriptional profile
by: Julia Cecilia Madela-Mönchinger, et al.
Published: (2023-11-01)

Transcutaneous immunization with a highly active form of XCL1 as a vaccine adjuvant using a hydrophilic gel patch elicits long-term CD8+ T cell responses
by: Momo Kamei, et al.
Published: (2020-07-01)

Structure-Function Relationship of XCL1 Used for in vivo Targeting of Antigen Into XCR1+ Dendritic Cells
by: Arthur L. Kroczek, et al.
Published: (2018-12-01)

New insights into the analgesic properties of the XCL1/XCR1 and XCL1/ITGA9 axes modulation under neuropathic pain conditions - evidence from animal studies
by: Agata Ciechanowska, et al.
Published: (2022-12-01)

The role of XCR1 and its ligand XCL1 in antigen cross-presentation by murine and human dendritic cells
by: Richard A. Kroczek, et al.
Published: (2012-02-01)

The XCL1-Mediated DNA Vaccine Targeting Type 1 Conventional Dendritic Cells Combined with Gemcitabine and Anti-PD1 Antibody Induces Potent Antitumor Immunity in a Mouse Lung Cancer Model
by: Ke Zhang, et al.
Published: (2024-02-01)

Involvement of the ERK/HIF-1α/EMT Pathway in XCL1-Induced Migration of MDA-MB-231 and SK-BR-3 Breast Cancer Cells
by: Ha Thi Thu Do, et al.
Published: (2020-12-01)

Conventional Type 1 Dendritic Cells in Intestinal Immune Homeostasis
by: Izumi Sasaki, et al.
Published: (2022-05-01)

Harnessing human cross-presenting CLEC9A+XCR1+ dendritic cells for immunotherapy
by: Kirsteen eTullett, et al.
Published: (2014-05-01)

CD8+XCR1neg Dendritic Cells Express High Levels of Toll-Like Receptor 5 and a Unique Complement of Endocytic Receptors
by: Ben Wylie, et al.
Published: (2019-01-01)

Targeting Xcr1 on Dendritic Cells Rapidly Induce Th1-Associated Immune Responses That Contribute to Protection Against Influenza Infection
by: Demo Yemane Tesfaye, et al.
Published: (2022-02-01)

Expression of XCR1 characterizes the Batf3-dependent lineage of dendritic cells capable of antigen cross-presentation
by: Annabell eBachem, et al.
Published: (2012-07-01)

Mouse conventional dendritic cells can be universally classified based on the mutually exclusive expression of XCR1 and SIRPα
by: Stephanie eGurka, et al.
Published: (2015-02-01)

Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells
by: João Calmeiro, et al.
Published: (2020-02-01)

Tolerogenic XCR1+ dendritic cell population is dysregulated in HLA-B27 transgenic rat model of spondyloarthritis
by: Kétia Ermoza, et al.
Published: (2019-02-01)

Development and function of chicken XCR1+ conventional dendritic cells
by: Zhiguang Wu, et al.
Published: (2023-10-01)

Multifaceted Roles of Chemokines and Chemokine Receptors in Tumor Immunity
by: Kazuhiko Matsuo, et al.
Published: (2021-12-01)

Novel Cre-Expressing Mouse Strains Permitting to Selectively Track and Edit Type 1 Conventional Dendritic Cells Facilitate Disentangling Their Complexity in vivo
by: Raphaël Mattiuz, et al.
Published: (2018-12-01)

CCR4 as a Therapeutic Target for Cancer Immunotherapy
by: Osamu Yoshie
Published: (2021-11-01)

Immunogenicity of the <i>Xcl1</i>-SARS-CoV-2 Spike Fusion DNA Vaccine for COVID-19
by: Hailong Qi, et al.
Published: (2022-03-01)

Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect
by: Sara Nava, et al.
Published: (2021-11-01)

Chemokines as Cancer Vaccine Adjuvants
by: Agne Petrosiute, et al.
Published: (2013-10-01)

Prognostic Implications of Heterogeneity in Intra-tumoral Immune Composition for Recurrence in Early Stage Lung Cancer
by: Jyothi Thyagabhavan Mony, et al.
Published: (2018-10-01)

Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce A “Hot” Tumor Microenvironment That Is Responsive to Immunotherapy
by: Robin Reschke, et al.
Published: (2022-05-01)

Systematic Pan-Cancer Analysis Reveals X-C Motif Chemokine Receptor 1 as a Prognostic and Immunological Biomarker
by: Likun Cui, et al.
Published: (2023-10-01)

Live images of donor Dendritic Cells trafficking via CX3CR1 pathway
by: Takuya Ueno, et al.
Published: (2016-10-01)

A candidate nanoparticle vaccine comprised of multiple epitopes of the African swine fever virus elicits a robust immune response
by: Jinxing Song, et al.
Published: (2023-11-01)

HHV-8 reduces dendritic cell migration through down-regulation of cell-surface CCR6 and CCR7 and cytoskeleton reorganization
by: Cirone Mara, et al.
Published: (2012-05-01)

Regulation of the Migration of Distinct Dendritic Cell Subsets
by: Meng Feng, et al.
Published: (2021-02-01)

The Role of Chemokines in Cervical Cancers
by: Fabian Garrido, et al.
Published: (2021-10-01)

Rat Cytomegalovirus Virion-Associated Proteins R131 and R129 Are Necessary for Infection of Macrophages and Dendritic Cells
by: Iris K. A. Jones, et al.
Published: (2020-11-01)

Dendritic cell-targeting chemokines inhibit colorectal cancer progression
by: Pengkun Yuan, et al.
Published: (2022-12-01)

New Insights into X-Chromosome Reactivation during Reprogramming to Pluripotency
by: Amitesh Panda, et al.
Published: (2020-12-01)

Murine Cytomegalovirus Spreads by Dendritic Cell Recirculation
by: Helen E. Farrell, et al.
Published: (2017-11-01)

Adjuvant immunotherapy with autologous dendritic cells for hepatocellular carcinoma, randomized phase II study
by: Jeong-Hoon Lee, et al.
Published: (2017-07-01)

Construction of a 13-Gene Signature as a Novel Prognostic Marker for Patients with Clear Cell Renal Cell Carcinoma and the Role of XCR1 in Cell Proliferation
by: Yuan B, et al.
Published: (2020-05-01)

CCR9-CCL25 mediated plasmacytoid dendritic cell homing and contributed the immunosuppressive microenvironment in gastric cancer
by: Hang Yu, et al.
Published: (2023-07-01)

Toll-Like Receptor 3 Signal in Dendritic Cells Benefits Cancer Immunotherapy
by: Misako Matsumoto, et al.
Published: (2017-12-01)

Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide
by: Serena Pellegatta, et al.
Published: (2018-04-01)